Cat-scratch disease (CSD) is a common infection caused by the bacterium Bartonella henselae. It typically presents as tender lymphadenopathy and is most commonly diagnosed in children after contact with an infected kitten or cat. The bacteria are transmitted via cat scratches or bites. Most cases are self-limited and do not require treatment. Rarely, CSD can involve the liver, spleen or central nervous system. Diagnosis is made based on a history of cat exposure and elevated antibody titers to B. henselae. While antibiotics may speed recovery, most cases resolve on their own without treatment.
2. SORT: KEY RECOMMENDATIONS FOR PRACTICE
Evidence
Clinical recommendation rating References
Cat-scratch disease should be included in the differential diagnosis in any C 2, 3
patient with lymphadenopathy.
The diagnosis of cat-scratch disease is usually confirmed by a history of cat C 3, 19
exposure and antibodies to Bartonella henselae.
Most cases of cat-scratch disease are self-limited and do not require B 4, 21, 23
antibiotic therapy.
If an antibiotic is chosen to treat cat-scratch disease, azithromycin B 22
(Zithromax) appears to be effective at reducing the duration of
lymphadenopathy.
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evi-
dence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information
about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.
in immunocompetent patients. One neu- peliosis. Bacillary peliosis is caused only by
rologic manifestation of CSD is encephalop- B. henselae and involves the liver and some-
athy, which manifests as severe headache and times the spleen. Bacillary angiomatosis
acute confusion one to six weeks after the can be caused by B. henselae and Bartonella
onset of lymphadenopathy. Seizures may quintana, and usually involves the skin and
occur, and occasionally patients have focal lymph nodes, but can also involve bone and
neurologic deficits that are self-limiting, but internal organs. Lesions consist of single or
can last up to one year. Parinaud oculoglan- multiple red to purple papules. Bacillary
dular syndrome is the most common ocular angiomatosis was first described in patients
manifestation and consists of granuloma- with AIDS with very low CD4 cell counts.
tous conjunctivitis and ipsilateral periauric- Evidence for previous Bartonella infection
ular lymphadenopathy. Neuroretinitis can is common in patients with human immu-
occur in CSD and manifests as acute unilat- nodeficiency virus infection living in Rio
eral visual field loss secondary to optic nerve de Janeiro, Brazil, and Bartonella infection
edema and star-shaped macular exudates. was detected in 18 percent of febrile patients
In immunosuppressed patients, B. hense- with human immunodeficiency virus infec-
lae can cause bacillary angiomatosis and tion living in San Francisco, Calif.
Diagnostic Testing
The Bartonella species are difficult to cul-
Table 1. Select Common Diseases ture, and culture is not routinely recom-
That May Be Confused with
mended. Serology is the best initial test and
Cat-scratch Disease Unilateral
Lymphadenopathy
can be performed by indirect fluorescent
assay or enzyme-linked immunosorbent
Infectious causes
assay. Although more sensitive than culture,
Cytomegalovirus lymphadenopathy*
serologic tests lack specificity because many
Epstein-Barr virus lymphadenopathy*
asymptomatic persons have positive serology
Group A streptococcal adenitis
because of previous (often asymptomatic)
Human immunodeficiency virus
exposure. The percentage of the general
lymphadenopathy* population that has a positive serologic test
Nontuberculous mycobacterial lymphadenitis varies widely, but appears to be higher in
Staphylococcus aureus adenitis cat owners. Immunoglobulin G titers less
Toxoplasmosis lymphadenopathy* than 1:64 suggest the patient does not have
Noninfectious causes current Bartonella infection. Titers between
Malignancy (lymphoma, leukemia [in children]) 1:64 and 1:256 represent possible infec-
tion; repeat testing should be performed in
*—Usually diffuse lymphadenopathy. these patients in 10 to 14 days. Titers greater
than 1:256 strongly suggest active or recent
January 15, 2011 ◆ Volume 83, Number 2 www.aafp.org/afp American Family Physician 153
3. Cat-scratch Disease
infection. A positive immunoglobulin M In a study from 1985, a single inves-
test suggests acute disease, but production of tigator evaluating 1,200 patients with
immunoglobulin M is brief. Immunoglobu- lymphadenopathy who were believed to have
lin G has significant cross-reactivity between CSD found that antibiotics were rarely used.4
B. henselae and B. quintana. Polymerase Physicians today occasionally employ antibi-
chain reaction can detect different Barton- otics in CSD. The results of one randomized
ella species; specificity is very trial support the use of oral azithromycin
Bacillary angiomatosis and high, but the sensitivity is lower (Zithromax) for mild to moderate disease
peliosis have high rates
than with serology. for five days (500 mg on day 1, followed by
of relapse and should be
Consequently, when a child 250 mg daily for four more days for patients
or adult presents with unilat- weighing more than 100 lb [45.5 kg]; or 10
treated with a prolonged
eral lymphadenopathy, the mg per kg on day 1, followed by 5 mg per kg
course of antibiotics.
physician should consider the for four more days for patients weighing 100
differential diagnoses provided lb or less).22 In this small study of 29 adult
in Table 1. A history of cat exposure should patients, the use of azithromycin led to a
be sought and appropriate tests ordered, more rapid resolution of lymphadenopathy
including serology for CSD. A history of cat than placebo; eight of 14 patients taking
exposure, lymphadenopathy, and elevated azithromycin had more than 80 percent
antibodies to B. henselae detected by enzyme- resolution at 30 days compared with one of
linked immunosorbent assay or indirect flu- 15 patients in the control group.22 The Infec-
orescent assay confirms the diagnosis. tious Diseases Society of America guidelines
Lymph node biopsy is not indicated for regarding CSD are equivocal about the rou-
most patients; however, it is appropriate in tine use of antibiotics,23 whereas another
patients whose lymph nodes fail to involute panel of authorities recommended against
and in whom diagnosis is uncertain. Lymph the use of antibiotics in patients with mild
node specimens in patients with CSD show or uncomplicated disease.21 Other antibi-
lymphoid hyperplasia and stellate granulo- otics that have been used in CSD include
mas. B. henselae is a small, curved, aerobic rifampin, ciprofloxacin (Cipro), trime-
gram-negative bacillus that stains with sil- thoprim/sulfamethoxazole (Bactrim, Sep-
ver. In bacillary angiomatosis, lobular pro- tra), and gentamicin.24
liferation of small blood vessels occurs with Treatment of bacillary angiomatosis and
the presence of bacilli in adjacent connec- peliosis, which have high rates of relapse,
tive tissue and blood vessels. In a series of with oral erythromycin or doxycycline for a
786 lymph node specimens from patients prolonged course of three to four months has
in whom CSD was suspected, only 245 benefited patients. Treatment with cell wall–
(31.2 percent) had evidence of CSD. Thir- active antibiotics has not. Treatment of
teen of the 245 patients had concurrent neurologic disease has not been evaluated,
mycobacteriosis or neoplasm. It is prudent but a combination of erythromycin or doxy-
that physicians follow up with patients who cycline plus rifampin for four to six weeks
have unilateral lymphadenopathy, even may be effective as suggested by case reports
those with confirmed CSD. of neuroretinitis.
Treatment
The Authors
Treatment of CSD depends on the disease
STEPHEN A. KLOTZ, MD, is a professor of medicine and
presentation. Most patients, especially chil- chief of the Section of Infectious Diseases at the University
dren, have self-limited lymphadenopathy of Arizona, Tucson.
lasting two to eight weeks and do not require VOICHITA IANAS, MD, is a senior fellow in adult infectious
antibiotics. Up to 14 percent of persons diseases at the University of Arizona.
develop dissemination to the liver, spleen, SEAN P. ELLIOTT, MD, is a professor of pediatrics in the
eye, or central nervous system and antibiot- Section of Pediatric Infectious Diseases at the University
ics may help. of Arizona.
154 American Family Physician www.aafp.org/afp Volume 83, Number 2 ◆ January 15, 2011
4. Cat-scratch Disease
Address correspondence to Stephen A. Klotz, MD, Uni- 13. Koehler JE, Tappero JW. Bacillary angiomatosis and bac-
versity of Arizona, 1501 N. Campbell Ave., Tucson, AZ illary peliosis in patients infected with human immuno-
85724 (e-mail: sklotz@u.arizona.edu). Reprints are not deficiency virus. Clin Infect Dis. 1993;17(4):612-624.
available from the authors. 14. Regnery RL, Childs JE, Koehler JE. Infections associated
with Bartonella species in persons infected with human
Author disclosure: Nothing to disclose. immunodeficiency virus. Clin Infect Dis. 1995;21(suppl
1):S94-S98.
REFERENCES 15. Lamas CC, Mares-Guia MA, Rozental T, et al. Bartonella
spp. infection in HIV positive individuals, their pets and
1. Jackson LA, Perkins BA, Wenger JD. Cat scratch disease ectoparasites in Rio de Janeiro, Brazil: serological and
in the United States: an analysis of three national data- molecular study. Acta Trop. 2010;115(1-2):137-141.
bases. Am J Public Health. 1993;83(12):1707-1711.
16. Koehler JE, Sanchez MA, Tye S, et al. Prevalence of
2. Zangwill KM, Hamilton DH, Perkins BA, et al. Cat Bartonella infection among human immunodeficiency
scratch disease in Connecticut. Epidemiology, risk fac- virus-infected patients with fever. Clin Infect Dis.
tors, and evaluation of a new diagnostic test. N Engl J 2003;37(4):559-566.
Med. 1993;329(1):8-13.
17. Bergmans AM, Peeters MF, Schellekens JF, et al. Pitfalls
3. Massei F, Gori L, Macchia P, Maggiore G. The expanded
and fallacies of cat scratch disease serology: evalua-
spectrum of bartonellosis in children. Infect Dis Clin
tion of Bartonella henselae-based indirect fluorescence
North Am. 2005;19(3):691-711.
assay and enzyme-linked immunoassay. J Clin Micro-
4. Carithers HA. Cat-scratch disease. An overview biol. 1997;35(8):1931-1937.
based on a study of 1,200 patients. Am J Dis Child.
18. Sander A, Posselt M, Oberle K, Bredt W. Seroprevalence
1985;139(11):1124-1133.
of antibodies to Bartonella henselae in patients with cat
5. Maman E, Bickels J, Ephros M, et al. Musculoskeletal
scratch disease and in healthy controls: evaluation and
manifestations of cat scratch disease. Clin Infect Dis.
comparison of two commercial serological tests. Clin
2007;45(12):1535-1540.
Diagn Lab Immunol. 1998;5(4):486-490.
6. Margileth AM, Wear DJ, English CK. Systemic cat
19. Spach DH, Kaplan SL. Microbiology, epidemiology, clini-
scratch disease: report of 23 patients with prolonged
cal manifestations, and diagnosis of cat scratch disease.
or recurrent severe bacterial infection. J Infect Dis.
UpToDate. http://www.uptodate.com. Accessed Sep-
1987;155(3):390-402.
tember 20, 2010.
7. Lenoir AA, Storch GA, DeSchryver-Kecskemeti K, et al.
Granulomatous hepatitis associated with cat scratch 20. Rolain JM, Lepidi H, Zanaret M, et al. Lymph node
disease. Lancet. 1988;1(8595):1132-1136. biopsy specimens and diagnosis of cat-scratch disease.
Emerg Infect Dis. 2006;12(9):1338-1344.
8. Tsujino K, Tsukahara M, Tsuneoka H, et al. Clinical impli-
cation of prolonged fever in children with cat scratch 21. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ,
disease. J Infect Chemother. 2004;10(4):227-233. Raoult D. Recommendations for treatment of human
9. Jacobs RF, Schutze GE. Bartonella henselae as a cause infections caused by Bartonella species. Antimicrob
of prolonged fever and fever of unknown origin in chil- Agents Chemother. 2004;48(6):1921-1933.
dren. Clin Infect Dis. 1998;26(1):80-84. 22. Bass JW, Freitas BC, Freitas AD, et al. Prospective ran-
10. Wong MT, Dolan MJ, Lattuada CP Jr, et al. Neuroreti- domized double blind placebo-controlled evaluation of
nitis, aseptic meningitis, and lymphadenitis associated azithromycin for treatment of cat-scratch disease. Pedi-
with Bartonella (Rochalimaea) henselae infection in atr Infect Dis J. 1998;17(6):447-452.
immunocompetent patients and patients infected with 23. Stevens DL, Bisno AL, Chambers HF, et al.; Infectious
human immunodeficiency virus type 1. Clin Infect Dis. Diseases Society of America. Practice guidelines for
1995;21(2):352-360. the diagnosis and management of skin and soft-tissue
11. Baorto E, Payne RM, Slater LN, et al. Culture-negative infections. Clin Infect Dis. 2005;41(10):1373-1406.
endocarditis caused by Bartonella henselae. J Pediatr. 24. Margileth AM. Antibiotic therapy for cat-scratch dis-
1998;132(6):1051-1054. ease: clinical study of therapeutic outcome in 268
12. Cunningham ET, Koehler JE. Ocular bartonellosis. Am J patients and a review of the literature. Pediatr Infect Dis
Ophthalmol. 2000;130(3):340-349. J. 1992;11(6):474-478.
January 15, 2011 ◆ Volume 83, Number 2 www.aafp.org/afp American Family Physician 155